Automated Neuropsychological Assessment Metrics (ANAM) Software
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Health Agency at Fort Sam Houston, Texas is seeking to award a sole source contract to Vista LifeSciences, LLC for the Automated Neuropsychological Assessment Metrics (ANAM) Software, with a base performance period starting July 30, 2026, lasting six months, and including one optional six-month extension. ANAM is an FDA-cleared, proprietary computer-based system that delivers over 30 cognitive tests, mood questionnaires, and reporting tools to evaluate attention, memory, and thinking ability, making it essential for military pre-deployment baseline assessments and clinical neurocognitive management. Vista LifeSciences holds the exclusive commercial and research license for ANAM, granting it sole authority to distribute software access keys, manage device installations, and maintain the cloud-based databases that support the system’s functionality. Any other potential provider must submit an authorized letter from the manufacturer with compelling evidence demonstrating legal authority to supply the software under the specified requirements. The solicitation, identified as HT0015-26-RFI-5902, was posted on July 10, 2026, with responses due by July 13, 2026, under NAICS code 513210, and no set-aside provisions apply. Primary point of contact is Joseph Preusser, with secondary contact Thomas Reese, both reachable via official government email addresses.
General Info
Agency
NAICS
Place of Performance
TX, 78234, USASet-Aside
Documents
(1)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Response Deadline
Organization & Contact Information
Full Description
The Defense Health Agency (DHA), Ft Sam Houston, TX intends to issue a sole source contract award to Vista LifeSciences, LLC for Automated Neuropsychological Assessment Metrics (ANAM) Software with a base period of performance beginning 30 Jul 2026 for six (6) months, and one (1) six-month option period.
ANAM is a proprietary, computer-based, FDA-cleared cognitive assessment tool designed to detect and measure the speed and accuracy of attention, memory, and thinking ability. The software suite, which includes over 30 cognitive tests, mood questionnaires, and reporting metrics, serves as a clinical and military-grade neurocognitive testing suite vital for pre-deployment baseline testing and clinical health system management.
Additionally, Vista LifeSciences, LLC holds the exclusive commercial and research license for the commercialization and deployment of the ANAM software. This exclusive license includes the sole authority to distribute software access keys, manage device installations, and maintain cloud-networked databases.
All interested sources may submit an authorized letter from the manufacturer with detailed information and convincing evidence that clearly demonstrates the authority to provide ANAM Software for the requirement as outlined above.
